March 17, 2020 / 12:07 PM / 22 days ago

BRIEF-Lattice Biologics Ltd. Announces Initial Recruitment Of Patients For A Phase 1 Clinical Trial To Access Safety And Efficacy Of Amnioboost For Treatment Of COVID-19

March 17 (Reuters) - Lattice Biologics Ltd:

* LATTICE BIOLOGICS LTD. ANNOUNCES INITIAL RECRUITMENT OF PATIENTS FOR A PHASE 1 CLINICAL TRIAL TO ACCESS SAFETY AND EFFICACY OF AMNIOBOOST FOR TREATMENT OF COVID-19

* LATTICE BIOLOGICS LTD - INITIAL PATIENT ENROLLMENT IN TRIAL WILL BE LIMITED TO 10 PATIENTS AND CONDUCTED IN SEATTLE AREA

* LATTICE BIOLOGICS LTD - CO WAS NAMED IN STATEMENT OF CLAIM FILED FORMER CFO, FOR WRONGFUL DISMISSAL IN AMOUNT OF $2.5 MILLION

* LATTICE BIOLOGICS - CO AND PLAINTIFF IN STATEMENT OF CLAIM BY FORMER CFO HAVE COME TO SATISFACTORY RESOLUTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below